CHARLES E MURRY
Medical Practice at Pacific St, Seattle, WA
License number
Washington MD00028871
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-6400
Professional information
Human Resources Professional
Location:
Greater Seattle Area
Industry:
Human Resources
Work:
Semi - Retired
2008 - 2012
-
HR Consultant
Semi-retired Human Resources Consultant
2008 - 2012
-
Semi-retired HR Consultant
Charles Emerson Murry, Seattle WA
Specialties:
Anatomic Pathology, Anatomic Pathology & Clinical Pathology
Work:
University Of Washington Medical Ctr
1959 Ne Pacific St, Seattle, WA 98195
1959 Ne Pacific St, Seattle, WA 98195
Education:
Duke University(1989)
Dr. Charles E Murry, Seattle WA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
Harborview Med Ctr Path
325 9Th Ave, Seattle 98104
(206) 744-3145 (Phone)
325 9Th Ave, Seattle 98104
(206) 744-3145 (Phone)
Certifications:
Anatomic Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Harborview Med Ctr Path
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
Education:
Medical School
Duke University School Of Medicine
Graduated: 1989
University Of Wa School Of Med
Duke University School Of Medicine
Graduated: 1989
University Of Wa School Of Med
Independent Human Resources Professional
Location:
Greater Seattle Area
Industry:
Human Resources
Human Resources Professional
Location:
Greater Seattle Area
Industry:
Human Resources
Charles J Murry, Seattle WA
Specialties:
Pathologist
Address:
University Of Washington Medical Ctr, Seattle, WA 98195
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Purified Compositions Of Stem Cell Derived Differentiating Cells
US Patent:
2006004, Feb 23, 2006
Filed:
Aug 17, 2004
Appl. No.:
10/920795
Inventors:
Charles Murry - Seattle WA, US
Michael Laflamme - Seattle WA, US
Michael Laflamme - Seattle WA, US
International Classification:
C12N 5/08, G01N 33/567
US Classification:
435377000, 435366000, 435007200
Abstract:
Viable differentiating cells from in vitro cultures of stem cells are selected for by partial dissociation to provide cell aggregates. Aggregates comprising cells of interest are selected for phenotypic features using methods that substantially maintain the cell to cell contacts in the aggregate.
Formulation To Improve Survival Of Transplanted Cells
US Patent:
2007016, Jul 19, 2007
Filed:
Jan 19, 2006
Appl. No.:
11/336502
Inventors:
Charles Murry - Seattle WA, US
Michael Laflamme - Seattle WA, US
Michael Laflamme - Seattle WA, US
International Classification:
A61K 35/12, C12N 5/08
US Classification:
424093700, 435366000
Abstract:
The survival of cells during transplantation is enhanced. Cells to be transplanted are administered in a formulation that provides two ore more survival enhancing factors. Optionally, prior to administration, the cells are cultured in the presence of factors that enhance survival, and may be heat shocked prior to transplantation.
Charles Murry
Location:
Greater Seattle Area
Industry:
Management Consulting
Charles Murry
Location:
Greater Seattle Area
Industry:
Research